Skip to main content

Tumor downsizing following neoadjuvant therapy for borderline-resectable pancreatic adenocarcinoma

Publication ,  Conference
Reza, JA; Monreal, A; Meyer, PH; Patel, S; Zakari, A; de la Fuente, S
Published in: JOURNAL OF CLINICAL ONCOLOGY
2020

Duke Scholars

Published In

JOURNAL OF CLINICAL ONCOLOGY

EISSN

1527-7755

ISSN

0732-183X

Publication Date

2020

Volume

38

Issue

4

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Reza, J. A., Monreal, A., Meyer, P. H., Patel, S., Zakari, A., & de la Fuente, S. (2020). Tumor downsizing following neoadjuvant therapy for borderline-resectable pancreatic adenocarcinoma. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 38).
Reza, Joseph Arturo, Alberto Monreal, Patrick Hunter Meyer, Swati Patel, Ahmed Zakari, and Sebastian de la Fuente. “Tumor downsizing following neoadjuvant therapy for borderline-resectable pancreatic adenocarcinoma.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 38, 2020.
Reza JA, Monreal A, Meyer PH, Patel S, Zakari A, de la Fuente S. Tumor downsizing following neoadjuvant therapy for borderline-resectable pancreatic adenocarcinoma. In: JOURNAL OF CLINICAL ONCOLOGY. 2020.
Reza, Joseph Arturo, et al. “Tumor downsizing following neoadjuvant therapy for borderline-resectable pancreatic adenocarcinoma.” JOURNAL OF CLINICAL ONCOLOGY, vol. 38, no. 4, 2020.
Reza JA, Monreal A, Meyer PH, Patel S, Zakari A, de la Fuente S. Tumor downsizing following neoadjuvant therapy for borderline-resectable pancreatic adenocarcinoma. JOURNAL OF CLINICAL ONCOLOGY. 2020.

Published In

JOURNAL OF CLINICAL ONCOLOGY

EISSN

1527-7755

ISSN

0732-183X

Publication Date

2020

Volume

38

Issue

4

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences